A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain

Summary

The purpose of this trial is to test the safety and tolerance of the combination therapy with cytarabine, lomustine and radiotherapy in patients with leptomeningeal metastasis from malignant melanoma.

Timeline

Start

2012-03

Primary completion

2015-11

Completion

2015-11

Outcome

Outcome not reported

Stopped (Enrollment): “No patients can be recruited for this trial anymore due to other therapeutical approaches that became available.”

Drugs

Indications